Deal of the Day — limited-time pharmacy picks!
Fempro 2.5mg Tablet

Fempro 2.5mg Tablet

Prescription requiredRx Required

Salt Composition: Letrozole

Expiry Date: 01/2028

Special offer

Buy at $1.62

$1.62

Inclusive of all taxes

▼

10 Tablets in Strip

About The Product

Breast Cancer

Fempro Tablet aids in the treatment of postmenopausal women's breast cancer. It can be used alone or in combination with other therapies like radiation or surgery. Patients with advanced breast cancer might use the hormone treatment medication.

Fempro 2.5 mg tablets are used to prevent the tumor from spreading to other body areas. The drug is an aromatase inhibitor and is marketed under the generic name letrozole.

Uses

Breast cancer

Side Effects

Most side effects of the Fempro 2.5 mg tablet do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.

  • Headaches
  • Heartburn
  • Muscle or joint pain
  • Vaginal bleeding 
  • Shortness of breath
  • Yellowing of skin or eyes
  • Nausea
  • Vomiting

How To Use

  • ​Fempro 2.5 mg tablets are a prescription-based medication that is taken orally with or without a meal as advised by the doctor.
  • In case of an overdose of Fempro tablets, contact your doctor or any healthcare provider and seek medical attention immediately.

How It Works

The CYP19A1 enzyme is blocked by the non-steroidal competitive aromatase inhibitor Fempro. As a result, the production of estrogen from androgens is stopped.

The cancers that rely on estrogen, a natural female hormone, decrease in number as its levels decline.

Some breast tumors that require estrogen to grow are less likely to spread when taken with these medications.

Safety Advice

Alcohol
It is advisable not to consume alcohol while taking medicine.
Pregnancy
Do not take Fempro 2.5 mg tablet without consulting the doctor, in case of pregnancy.
Breast Feeding
Without a doctor's consultation, do not take this medicine if you're breastfeeding.
Driving
It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of the medicine.
Kidney
Do not take Fempro 2.5 mg tablet without a doctor's consultation in case of kidney problems.
Liver
Share your medical history with the doctor in case of liver disease before taking this medicine.

Missed Doses

  • If you forget to take a dose of Fempro 2.5 mg tablet consult your doctor.
  • Don’t double up the next dose to cope with the missed one unless your doctor recommends it. ​

FAQs

​ Fempro tablet is an anticancer tablet that is used for the treatment of breast cancer.

​

Reference

Fjermeros, K., Ghannoum, S., Geisler, S. B., Bhargava, S., Tahiri, A., Klajic, J., Geisler, J.

(2024). The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer.

Future Oncology, 20(32), 2457–2466 - https://pubmed.ncbi.nlm.nih.gov/39073142/ Konstantinopoulos, P. A., et al.

(2025). Treatment of recurrent endometrial cancer with metformin, letrozole, and abemaciclib is safe and promising.

Presented at the Society of Gynecologic Oncology Annual Meeting, Seattle - https://www.dana-farber.org/newsroom/news-releases/2025/treatment-of-recurrent-endometrial-cancer-with-metformin-letrozole-and-abemaciclib-is-safe-and-promising-dana-farber-research-shows Lin, J., Wu, F., Wang, B., et al. (2024).

Impact of letrozole co‑treatment in an antagonist protocol for IVF/ICSI: A retrospective study. Reproductive Biology and Endocrinology, 22, 126 - https://pubmed.ncbi.nlm.nih.gov/39415184/ Mirza, M.

R., Bjørge, L., Marmé, F., et al. (2025).

Palbociclib plus letrozole in estrogen receptor‑positive advanced/recurrent endometrial cancer: double‑blind placebo‑controlled randomized phase II ENGOT‑EN3/PALEO trial. Gynecologic Oncology, 192, 128–136 - https://pubmed.ncbi.nlm.nih.gov/39657575/ Xie, Y., Li, P., Hao, G. et al.

(2025). Letrozole ovulation Regimen for frozen-thawed embryo transfer in women with polycystic ovary syndrome: a multi-centre randomised controlled trial.

Reprod Biol Endocrinol 23, 103.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026